Adult patients who receive the RSVpreF #vaccine do not experience a higher incidence of #myocarditis or #pericarditis compared with unvaccinated individuals.
www.thecardiologyadvisor.com/news/r…
thecardiologyadvisor.com
RSVpreF Vaccine Does Not Increase Myocarditis Risk
The respiratory syncytial virus prefusion F protein-based vaccine does not increase the risk for severe myocarditis or pericarditis in adults.